Molina Healthcare, INC 8-K filings

Molina Healthcare reported Q2 2026 results, with adjusted EPS of $1.51, and raised its full-year 2026 adjusted earnings guidance to at least $5.25 per diluted share.

Molina Healthcare has been selected by the Illinois Department of Healthcare and Family Services to provide managed care services under the HealthChoice Illinois program.

Molina Healthcare's 2026 Annual Meeting saw stockholders approve amendments to the 2025 Equity Incentive Plan and the Certificate of Incorporation, alongside director elections and executive compensation.

Molina Healthcare, Inc. announced its Investor Day Conference on May 8, 2026, where it will provide updates on its business, long-term financial targets, and strategic plans.

Molina Healthcare reported Q1 2026 adjusted EPS of $2.35 and reaffirmed its full-year 2026 adjusted earnings guidance of at least $5.00 per share.

Molina Healthcare, Inc. reaffirms its 2026 full-year GAAP diluted EPS guidance of at least $3.20 and adjusted diluted EPS guidance of at least $5.00 ahead of upcoming investor engagements.

Molina Healthcare revised its credit agreement's interest coverage ratio and announced a $93 million impairment charge related to exiting a Medicare product.

Molina Healthcare reported a fourth-quarter 2025 GAAP loss per diluted share of $3.15 and introduced lower full-year 2026 earnings guidance.

Molina Healthcare, Inc. successfully closed a private offering of $850 million 6.500% Senior Notes due 2031 and entered into a new credit agreement with favorable covenant amendments.

Molina Healthcare, Inc. announced the pricing of $850 million in 6.500% senior notes due 2031, with net proceeds intended for general corporate purposes and debt repayment.

Molina Healthcare, Inc. announced its intent to privately offer $750 million in senior notes due 2031 and establish a new revolving credit facility.

Molina Healthcare of Florida has been selected as the sole provider for a significant Statewide Medicaid Managed Care and CHIP contract in Florida, expected to serve 120,000 enrollees.

Molina Healthcare, Inc. reported third quarter 2025 financial results, including GAAP EPS of $1.51 and adjusted EPS of $1.84, and revised its full-year 2025 earnings guidance downwards due to higher medical cost trends.

Molina Healthcare, Inc. amended its credit agreement to secure a new $500 million delayed draw term loan facility, primarily to partially fund its stock repurchase program.

Molina Healthcare reported lower-than-expected second-quarter earnings and revised its full-year 2025 adjusted earnings guidance downward, citing a challenging medical cost trend environment.

Molina Healthcare announced preliminary second-quarter results below expectations and reduced its full-year 2025 adjusted earnings per share guidance due to accelerating medical cost pressures.

Molina Healthcare's stockholders approved the 2025 Equity Incentive Plan at the Annual Meeting on April 30, 2025, aiming to attract, retain, and reward individuals contributing to the company's growth and profitability.

Molina Healthcare announced its first quarter 2025 financial results, reporting GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08, while reaffirming its full-year 2025 revenue and earnings guidance.

Molina Healthcare's subsidiary, Molina Healthcare of Illinois, has been awarded a contract to provide a Fully Integrated Dual Eligible Special Needs Plan (D-SNP) by the Illinois Department of Healthcare and Family Services.

Molina Healthcare amends its credit agreement to include a $500 million delayed draw term loan facility, enhancing financial flexibility.

Molina Healthcare announces positive fourth quarter and year-end 2024 financial results, along with an encouraging full-year 2025 revenue and earnings guidance.

Molina Healthcare successfully closed its acquisition of ConnectiCare Holding Company, Inc. effective February 1, 2025, adding approximately 140,000 members to its portfolio.

Molina Healthcare has been awarded contracts in Michigan and is intended to be awarded contracts in Idaho to provide healthcare services to dual eligible populations.

Molina Healthcare successfully completed a private offering of $750 million in senior notes due 2033, with net proceeds intended for general corporate purposes.

Molina Healthcare has announced the pricing of a $750 million private offering of senior notes due in 2033.

Molina Healthcare plans to privately offer $500 million in senior notes due in 2033, with proceeds intended for general corporate purposes.

Molina Healthcare's potential contract award in Michigan for dual-eligible Medicare benefits has been cancelled, with the state reissuing the request for proposal.

Molina Healthcare hosted its Investor Day on November 8, 2024, reaffirming its full-year 2024 guidance and providing updates on performance, long-term financial targets, and strategic plans.

Molina Healthcare announced a robust third quarter with increased revenue and earnings, while also reaffirming its full-year 2024 financial guidance.

Molina Healthcare's Compensation Committee granted a special one-time stock award to CFO Mark L. Keim, contingent on achieving long-term financial targets and continued employment.